Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001078782-20-000011
Filing Date
2020-01-10
Accepted
2020-01-10 16:21:31
Documents
1
Period of Report
2020-01-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2901
  Complete submission text file 0001078782-20-000011.txt   4500
Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Issuer) CIK: 0001570562 (see all company filings)

EIN.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4040 MACARTHUR BOULEVARD, SUITE 310 NEWPORT BEACH CA 92660
Business Address 4040 MACARTHUR BOULEVARD, SUITE 310 NEWPORT BEACH CA 92660 (949) 260-1700
Alphaeon 1 LLC (Reporting) CIK: 0001799102 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38381 | Film No.: 20521287